ST段抬高型心肌梗死（STEMI）的最佳治疗：新的药物和器械治疗方法。

The optimal treatment of STEMI: new pharmacological and device approaches.

机构信息

CareMore Health Care Arizona, Division of Cardiology The Southern Arizona VA health Care System Tucson, Arizona and Division of Cardiology University of Arizona, Tucson, AZ, USA -

出版信息

Panminerva Med. 2013 Dec;55(4):339-43.

PMID:24434342

Abstract

Cardiovascular disease remains the leading cause of mortality worldwide. Many deaths are contributed to acute ST elevation myocardial infarction (STEMI). Recently, epidemiological studies have been shown reduction in STEMI related mortality over the last decade. This reduction has partially been attributed to new pharmacological and device advances that were utilized during STEMI treatment. The goal of this manuscript is to review new pharmacological and device approaches available in the treatment of STEMI patients.

摘要

心血管疾病仍然是全球范围内导致死亡的主要原因。许多死亡是由于急性 ST 段抬高型心肌梗死（STEMI）引起的。最近的流行病学研究表明，在过去十年中，STEMI 相关死亡率有所下降。这种减少部分归因于在 STEMI 治疗中使用的新的药理学和器械方面的进步。本文的目的是回顾 STEMI 患者治疗中可用的新的药理学和器械方法。